Analysis of Protein Phosphatase in Oral Colorectal Cancer
Analysis of Protein Phosphatase in Oral Colorectal Cancer
批准号:
07672159
负责人:
FUJII Eiji
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It is known that phosphorylation of retinoblastoma protein (pRb) is necessary for G1 to S phase transition. By the treatment of transforming growth factor (TGF)-beta, HaCaT cell which is derived from normal human epithelia shows growth arrest at G1 phase and pRb is dephosphorylated at that time. It is also known that activation of protein phosphatase (PP) type 2A and 1 are necessary for G2/M and G1/S transition, respectively.In this study, we investigated the phospholyration status of pRb and intracellular localization of PPs in HaCaT compared with other oral cancer cell lines, HSC4, HSC3 and HOC313. By TGF-beta treatment, HSC4 showed growth arrest at G1 phase and dephosphorylation of pRb as well as HaCaT.In contrast, HSC3 and HOC313 did not arrest at G1 and pRb was phospholyrated.To further characterize the intra-cellular localization of PPs, nuclear and cytoplasmic protein from each cell were extracted 24 hours after the treatment of 2ng/ml TGF-beta, and western blot analysis were performed using specific antibodies against individual PP isotypes. The expression levels of PP1gamma1 in nucleus of HSC3, HOC313, HSC4 and HaCaT were rated 1 : 1 : 1 : 4. With TGF-beta treatment, those of HSC3, HOC313 were still 1 : 1, but HSC4, HaCaT were reduced to 0 : 1.For PP1alpha, the levels were 1 : 1 : 0 : 2. With TGF-beta treatment, those of HSC3, HOC313 and HSC4 were still 1 : 1 : 0, but HaCaT was reduced to 1.These results demonstrated that the extents of phosphorylated pRb were related inversely to the expression levels of PP1gamma1 and PP1alpha in nucleus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Market-government paradox under globalization: Analyzing consistency, comlementarity, and substitutability
-
批准号:25285087
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.74万
-
财政年份:2013
-
负责人:FUJII Eiji
-
依托单位:
Analysis on structural changes and imbalances of the world economy
-
批准号:20530263
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.41万
-
财政年份:2008
-
负责人:FUJII Eiji
-
依托单位:
Structural shifts in monetary policy conduct, inflation environment, and exchange rate pass-through
-
批准号:17530205
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.07万
-
财政年份:2005
-
负责人:FUJII Eiji
-
依托单位:
A study on behavioral dynamics of relative prices and retail market integration
-
批准号:14530039
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2002
-
负责人:FUJII Eiji
-
依托单位:
Chromatological and immunohistochemical study of oral premalignant lesions-Evaluation of mailgnant potentiality-
-
批准号:05671659
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1993
-
负责人:FUJII Eiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AAV介导sTGF-betaRII抑制TGF-beta/Smad2/3信号通路的抗口腔黏膜下纤维化基因治疗研究
-
批准号:JCZRLH202600804
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
-
批准号:82303919
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈鹭跃
-
依托单位:
靶向TGF-beta Ⅱ型受体的核酸适配子对TGF-beta介导PCO形成的抑制作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:朱小敏
-
依托单位:
癌基因FBN2通过TGF-beta通路促进胃癌肝转移的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:舒洋
-
依托单位:
转录因子FOXA1对TGF-beta介导的肺癌细胞上皮-间充质转化调控作用的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王学聪
-
依托单位:
端粒缩短触发NLRP3/TGF-beta/Smad3信号通路对IgA肾病重症进展的调控研究
-
批准号:82100738
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:任萍萍
-
依托单位:
BRD2 通过相变调控 TGF-beta 信号通路的分子机制和功能研究
-
批准号:LZ22C070001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:顾舒晨
-
依托单位:
非经典TGF-beta信号通路调控小肠干细胞稳态的作用及机制研究
-
批准号:32000538
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘连胜
-
依托单位:
TGF-beta信号通调控淋巴管形成在单纯疱疹病毒性角膜炎治疗中的作用
-
批准号:82060175
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:张慧
-
依托单位:
TGF-beta信号通路促进人类T细胞白血病1型病毒侵染的作用及其机制研究
-
批准号:LY21C010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:赵铁军
-
依托单位: